Ability of nitrobenzylthioinosine to cross the blood-brain barrier in rats

Neuroscience Letters

Volumn 219, Issue 3, 1996, Pages 191-194

  Anderson, Christopher M ^a   Sitar, Daniel S ^a   Parkinson, Fiona E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adenosine; Adenosine transport; Blood brain barrier; Cerebral ischemia; Cerebrospinal fluid; Nitrobenzylthioinosine

Indexed keywords

NITROBENZYLTHIOINOSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; RAT;

ANIMALS; BINDING, COMPETITIVE; BLOOD-BRAIN BARRIER; BRAIN; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUCROSE; THIOINOSINE; THIONUCLEOTIDES;

EID: 0030606242     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13220-1     Document Type: Article

References (15)

1. 3H]nitrobenzylthioinosine, J. Neurosci., 5 (1985) 544-550.
2. [2] Brown, R.D. and Manno, J.E., ESTRIP, a basic computer program for obtaining initial polyexponential parameter estimates, J. Pharmacol. Sci., 67 (12)(1978) 1687-1691.
3. 50) of an enzymatic reaction, Biochem. Pharmacol., 22 (1973) 3099-3108.
4. [4] Crawley, J.N., Patel, J. and Marangos, P.J., Adenosine uptake inhibitors potentiate the sedative effects of adenosine, Neurosci. Lett., 36 (1983) 169-174.
5. [5] Delaney, S.M. and Geiger, J.D., Brain levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation, J. Neurosci. Methods, 64 (1996) 151-156.
6. [6] Delaney, S.M. and Geiger, J.D., Enhancement of NMDA-induced increases in levels of endogenous adenosine by adenosine deaminase and adenosine transport inhibition in rat striatum, Brain Res., 702 (1995) 72-76.
7. [7] DeLeo, J., Schubert, P. and Kreutzberg, G.W., Propentofylline (HWA 285) protects hippocampal neurons of Mongolian gerbils against ischemic damage in the presence of an adenosine antagonist, Neurosci. Lett., 84 (1988) 307-311.
8. [8] Gati, W.P. and Paterson, A.R., Measurement of nitrobenzylthioinosine in plasma and erythrocytes: a pharmacokinetic study in mice, Cancer Chemother. Pharmacol. (1996) in press.
9. [9] Geiger, J.D. and Fyda, D.M., Adenosine transport in nervous system tissues. In: T.L. Stone (Ed.), Adenosine in the Nervous System, T. Stone, London, 1991, pp. 1-22.
10. [10] Hoque, A.N.E., Hoque, N., Hashizume, H. and Abiko, Y., A study on dilazep: I. Mechanism of anti-ischemic action of dilazep is not coronary vasodilation but decreased cardiac mechanical function in the isolated, working rat heart, Jpn. J. Pharmacol., 67 (1995) 225-232.
11. [11] Parkinson, F.E., Rudolphi, K.A. and Fredholm, B.B., Propentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia, Gen. Pharmacol., 25 (1994) 1053-1058.
12. [12] Rudolphi, K.A., Schubert, P., Parkinson, F.E. and Fredholm, B.B., Neuroprotective role of adenosine in cerebral ischaemia, Trends Pharmacol. Sci., 13 (1992) 439-445.
13. [13] Samii, A., Bickel, U., Stroth, U. and Pardridge, W.M., Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue, Am. J. Physiol., 267 (1994) E124-E131.
14. [14] Walter, G.A., Phillis, J.W. and O'Reagan, M.H., Determination of rat cerebrospinal fluid concentrations of adenosine, inosine, hypoxanthine, xanthine and uric acid by high performance liquid chromatography, J. Pharm. Pharmacol., 40 (1988) 140-142.
15. [15] Yoshikawa, T. and Pardridge, W.M., Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor, J. Pharmacol. Exp. Ther., 263 (1992) 897-903.